bit.ly
Latest Advances in Hemophilia Treatment: Gene Therapy, Monoclonal Antibodies & More
Watch now and stay ahead in hemophilia treatment! Learn more: https://oncdata.com/additional-advances-in-hemophilia-treatment/ 0:00 Introduction 0:30 Updates in Hemophilia Treatment 1:32 Updates in Gene Therapy 3:51 Ongoing Trials and Research Directions 6:45 Why is it important to stay educated? 9:30 Key Takeaways Explore the latest breakthroughs in hemophilia treatment with Dr. Guy Young, Director of the Hemostasis and Thrombosis Program at USC, as he shares key updates from recent clinical trials and FDA approvals. - New Monoclonal Antibodies: Marstacimab and concizumab offer expanded treatment options for hemophilia A and B. - Gene Therapy Innovations: Promising data on giroctocogene fitelparvovec and novel gene editing techniques for hemophilia B. - Oral Therapeutics: The first-ever oral bispecific antibody for hemophilia is entering clinical trials. - Rebalancing Agents: Fitusiran shows improved bleed management with fewer interventions. With rapid advancements in hemophilia care, staying informed is essential. Join Dr. Young as he discusses how these developments are shaping the future of hemophilia management. #hemophilia #GeneTherapy #PrecisionMedicine #MonoclonalAntibodies #BloodDisorders #Hematology #MedicalBreakthrough #CME #HealthcareEducation #RareDiseases
